- Home
- AXS vs LNTH Comparison
AXS vs LNTH Comparison
Compare AXS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXS
- LNTH
- Stock Information
- Founded
- AXS 2001
- LNTH 1956
- Country
- AXS Bermuda
- LNTH United States
- Employees
- AXS N/A
- LNTH N/A
- Industry
- AXS Property-Casualty Insurers
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AXS Finance
- LNTH Health Care
- Exchange
- AXS Nasdaq
- LNTH Nasdaq
- Market Cap
- AXS 8.1B
- LNTH 7.5B
- IPO Year
- AXS N/A
- LNTH 2015
- Fundamental
- Price
- AXS $102.54
- LNTH $81.24
- Analyst Decision
- AXS Strong Buy
- LNTH Strong Buy
- Analyst Count
- AXS 9
- LNTH 5
- Target Price
- AXS $107.75
- LNTH $133.80
- AVG Volume (30 Days)
- AXS 565.6K
- LNTH 1.4M
- Earning Date
- AXS 04-30-2025
- LNTH 05-07-2025
- Dividend Yield
- AXS 1.72%
- LNTH N/A
- EPS Growth
- AXS 54.31
- LNTH N/A
- EPS
- AXS 10.08
- LNTH 3.53
- Revenue
- AXS $6,055,200,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- AXS $4.15
- LNTH $4.96
- Revenue Next Year
- AXS $5.74
- LNTH $10.25
- P/E Ratio
- AXS $10.14
- LNTH $23.00
- Revenue Growth
- AXS 5.79
- LNTH 12.53
- 52 Week Low
- AXS $68.02
- LNTH $74.34
- 52 Week High
- AXS $101.42
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- AXS 64.39
- LNTH 32.82
- Support Level
- AXS $98.40
- LNTH $77.01
- Resistance Level
- AXS $102.36
- LNTH $83.60
- Average True Range (ATR)
- AXS 2.23
- LNTH 3.77
- MACD
- AXS 0.26
- LNTH -2.21
- Stochastic Oscillator
- AXS 99.79
- LNTH 13.26
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.